Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21d03c7c814b4a81ce7bdb05b212d857 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1763f7f78d01cad638210d060676591a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0318 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2330-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-141 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14143 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y115-01001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 |
filingDate |
2018-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_769447b94bc1824763757e17d08e7614 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aee9dcdf95873d88a2361d55cb2d2a09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfbc9c829fcfcb3c0c014f342fd11510 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ae26e2a4b4becaf967ac223d0b0a498 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4c8f02bbb29bd0b8c3e5e93a39d1abc |
publicationDate |
2020-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2020239912-A1 |
titleOfInvention |
Treatment of amyotrophic lateral sclerosis (als) |
abstract |
The present invention relates to AAVs encoding a SOD1 targeting polynucleotide which may be used to treat amyotrophic lateral sclerosis (ALS) and/or canine degenerative myelopathy (DM). |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11603542-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11542506-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023092002-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11474113-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11434502-B2 |
priorityDate |
2017-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |